Indication

Long-chain fatty acid oxidation disorder

A long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids. Read more about Long-chain fatty acid oxidation disorder

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Long-chain fatty acid oxidation disorder therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Long-chain fatty acid oxidation disorder preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Long-chain fatty acid oxidation disorder.

A long-chain fatty acid oxidation disorder is a rare, autosomal recessive inborn error of metabolism caused by enzyme deficiencies in the mitochondrial transport or beta-oxidation of long-chain fatty acids.

This metabolic block impairs cellular energy production from lipids during periods of prolonged fasting, acute illness, or sustained physical exertion.

It predominantly affects high-energy organ systems across neonatal, pediatric, and adult populations, primarily involving cardiac tissue, skeletal muscle, and the liver.

Pathophysiologically, the failure to generate downstream acetyl-CoA and ketone bodies triggers severe hypoketotic hypoglycemia, hyperammonemia, hepatic dysfunction, hypertrophic or dilated cardiomyopathy, and recurrent rhabdomyolysis.

Personalize your experience

Follow Long-chain fatty acid oxidation disorder and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it